Agenda
Please check back shortly for the latest agenda.
Thursday, September 26, 2024
Session I: From Cytokines to Cells for Melanoma
Michael T. Lotze, M.D., University of Pittsburgh
James Mulé, IPh.D., Moffitt Cancer Center
Stephanie Goff, M.D., Center for Cancer Research, NCI
SESSION II: Antigen Discovery
Yutaka Kawakami, M.D., Ph.D., International University of Health and Welfare
Paul Robbins, Ph.D., Center for Cancer Research, NCI
James Yang, M.D., Center for Cancer Research, NCI
Alena Gros, Ph.D., Vall D'Hebon Institute of Oncology
Ken-Ichi Hanada, Ph.D., Center for Cancer Research, NCI
FAES Terrace
SESSION III: Bench to Bedside: TIL and T-Cell Receptor Therapy
Moderator: Stephanie Goff, M.D., Center for Cancer Research, NCI
Monica Bertagnolli, M.D., Director, National Institutes of Health
Steven Rosenberg, M.D., Ph.D., Center for Cancer Research, NCI
Richard Morgan, Ph.D., Be Biopharma
Maria Parkhurst, Ph.D., Center for Cancer Research, NCI
Frank Lowery, Ph.D., Center for Cancer Research, NCI
Eric Tran, Ph.D., Providence Cancer Institute
Session IV: Bench to Bedside: Chimeric Antigen Receptor Therapy
Patrick Hwu, M.D., Moffitt Cancer Center
James Kochenderfer, M.D., Center for Cancer Research, NCI
Crystal Mackall, M.D., Stanford University
Friday, September 27, 2024
SESSION V: Advances in Checkpoint Inhibitor Blockade
James Allison, Ph.D., MD Anderson Cancer Center
Suzanne Topalian, M.D., Johns Hopkins University
SESSION VI: Optimizing Cell Phenotype for Clinical Translation
Nicholas Restifo, M.D., Marble Therapeutics
Sri Krishna, Ph.D., Center for Cancer Research, NCI
Chrystal Paulos, Ph.D., Winship Cancer Institute at Emory University
SESSION VII: Optimizing Tumor Microenvironment for Clinical Translation
Jennifer Wargo, M.D. MD Anderson Cancer Center
Rosandra Kaplan, M.D., Center for Cancer Research, NCI
Award presented by Kimryn Rathmell, M.D., Ph.D., Director, National Cancer Institute